Novo Nordisk Falls Most on Record After New Weight Drug Disappoints
Novo Nordisk A/S’s shares fell by the most on record after patients using its experimental obesity shot CagriSema lost less ...
Zacks.com on MSN13d
Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note
Novo Nordisk (NVO) closed the most recent trading day at $87.37, moving -1.51% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 1.1%. At the same time, ...